EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive
Recent news
« of 2 »






Recent news

» Melflufen receives positive opinion from the European Medicines Agency (EMA) for the treatment of refractory myeloma

» EHA 2022 highlights in myeloma and AL amyloidosis